Danimer Scientific Quarterly report pursuant to Section 13 or 15(d)

Revenue (Tables)

6 Months Ended

Jun. 30, 2022

The following table shows the significant changes in the R&D contract asset and contract liability balances.


	June 30, 2022						December 31, 2021
(in thousands)	Contract Assets			Contract Liabilities			Contract Assets		Contract Liabilities
Beginning balance	$	2,128		$	(214	)	$	-	$	(2,115	)
Revenue recognized in the quarter ended:
March 31		(582	)		582			-		1,397
June 30		2,038			210			1,530		1,513
September 30		-			-			6		572
December 31		-			-			592		675
Total revenue recognized		1,456			792			2,128		4,157
Unearned consideration received in the quarter ended:
March 31		-			(368	)		-		(1,600	)
June 30		(50	)		(2,500	)		-		-
September 30		-			-			-		-
December 31		-			-			-		(656	)
Total unearned consideration received		(50	)		(2,868	)		-		(2,256	)
Reserves recorded in the quarter ended:
June 30		(1,215	)		-			-		-
Ending balance	$	2,319		$	(2,290	)	$	2,128	$	(214	)

Revenue by geographic areas is based on the location of the customer. The following is a summary of revenue information by major geographic area: